Rottapharm
Rottapharm's Irish operation in Damastown Industrial Park in Mulhuddart manufactures and sells drugs used in the treatment of osteo-arthritis, on behalf of its Italian parent Rottapharm/Madaus. It trades as Meda Manufacturing Dublin.
Financial Data
-
31st Dec 20 Source: CRO
- €143.6 million turnover
-
€24.3 million
profit - 306 employees
-
31st Dec 19 Source: CRO
- €143.2 million turnover
-
€49.9 million
profit - 233 employees
- 9 more years available »
Ranking
By Turnover
(€143.6 million)- 396th in Top Companies
- 40th in Pharma
- 61st in Manufacturing
By Employees
(306)- 497th in Top Companies
- 46th in Pharma
- 72nd in Manufacturing
-
- 306
- €143.6 million
Employees
- Patrick Garraghy CEO/Managing Director
Latest News
- 5:55am Consumer giant Procter & Gamble sells last Irish manufacturing plant
- 2:02am Nama clashes with Fingal council over lands with space for up to 7,000 new homes
- May 20 Attempt by investors to appoint inspector to firm ‘without precedent’, court hears
- May 20 Amarenco and SSE among groups to win green Eirgrid contracts
- May 20 Cerberus collected €113m last year from Irish loans it bought after the 2008 crash